Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Pearson
PSO
$9.72B
| $1.31M | ﹤0.01% |
+106,400
| New | +$1.24M |
|
|
GNTY
2227
DELISTED
Guaranty Bancshares
GNTY
| $1.3M | ﹤0.01% |
38,829
-1,700
| -4% | -$50.9K |
|
2228
Immunome
IMNM
$3.09B
| $1.3M | ﹤0.01% |
121,500
+89,100
| +275% | +$741K |
|
|
CGAU
2229
Centerra Gold
CGAU
$4.21B
| $1.3M | ﹤0.01% |
+217,500
| New | +$1.19M |
|
|
STRR
2230
Star Equity Holdings
STRR
$36.2M
| $1.3M | ﹤0.01% |
83,765
+1,700
| +2% | +$28K |
|
2231
Cardlytics
CDLX
$24.9M
| $1.3M | ﹤0.01% |
14,084
+7,290
| +107% | +$741K |
|
2232
Xtrackers S&P 500 ESG ETF
SNPE
$2.79B
| $1.3M | ﹤0.01% |
29,800
+16,400
| +122% | +$671K |
|
2233
Embotelladora Andina Series A
AKO.A
$3.75B
| $1.3M | ﹤0.01% |
99,700
-1,700
| -2% | -$19.2K |
|
|
ALLK
2234
DELISTED
Allakos
ALLK
| $1.3M | ﹤0.01% |
474,711
-835,748
| -64% | -$1.88M |
|
2235
Arcos Dorados Holdings
ARCO
$1.67B
| $1.3M | ﹤0.01% |
102,134
-523,600
| -84% | -$5.61M |
|
2236
Eagle Bancorp Montana
EBMT
$187M
| $1.3M | ﹤0.01% |
82,051
+11,441
| +16% | +$143K |
|
|
GOLD
2237
Gold.com Inc
GOLD
$1.28B
| $1.28M | ﹤0.01% |
42,493
-242,800
| -85% | -$6.92M |
|
2238
Yext
YEXT
$594M
| $1.28M | ﹤0.01% |
218,100
-291,700
| -57% | -$1.79M |
|
|
NINE
2239
DELISTED
Nine Energy Service
NINE
| $1.28M | ﹤0.01% |
477,936
-38,000
| -7% | -$110K |
|
2240
Triple Flag Precious Metals
TFPM
$6.48B
| $1.28M | ﹤0.01% |
96,200
+1,100
| +1% | +$14.4K |
|
|
MBCN
2241
DELISTED
Middlefield Banc Corp
MBCN
| $1.28M | ﹤0.01% |
39,512
-300
| -0.8% | -$8.64K |
|
2242
Arcutis Biotherapeutics
ARQT
$3.29B
| $1.28M | ﹤0.01% |
+395,100
| New | +$1.07M |
|
|
BHR
2243
Braemar Hotels & Resorts
BHR
$139M
| $1.27M | ﹤0.01% |
508,600
+16,600
| +3% | +$41.3K |
|
2244
RLJ Lodging Trust
RLJ
$1.67B
| $1.27M | ﹤0.01% |
108,132
-466,100
| -81% | -$4.84M |
|
2245
Black Diamond Therapeutics
BDTX
$116M
| $1.27M | ﹤0.01% |
450,400
+121,500
| +37% | +$285K |
|
2246
EverQuote
EVER
$861M
| $1.27M | ﹤0.01% |
103,408
-73,335
| -41% | -$667K |
|
2247
Liquidia Corp
LQDA
$6.66B
| $1.26M | ﹤0.01% |
105,089
-146,345
| -58% | -$1.05M |
|
2248
Northern Technologies International Corp
NTIC
$75.9M
| $1.26M | ﹤0.01% |
107,077
-100
| -0.1% | -$1.19K |
|
2249
Amneal Pharmaceuticals
AMRX
$6.32B
| $1.26M | ﹤0.01% |
207,800
+93,700
| +82% | +$417K |
|
|
VLRS
2250
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $1.26M | ﹤0.01% |
134,200
-173,400
| -56% | -$1.26M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.